Mifepristone (generic), Mifeprex, RU-486 Newswire (Page 3)

Mifepristone (generic), Mifeprex, RU-486 Newswire (Page 3)

Comprehensive Real-Time News Feed for Mifepristone (generic), Mifeprex, RU-486. (Page 3)

Results 41 - 60 of 589 in Mifepristone (generic), Mifeprex, RU-486

  1. Corcept Therapeutics Incorporated (CORT) Director Sells $81,375.00 in StockRead the original story w/Photo

    Aug 11, 2017 | IntersportsWire

    Corcept Therapeutics Incorporated Director David L. Mahoney sold 6,510 shares of the company's stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $12.50, for a total transaction of $81,375.00.

    Comment?

  2. You can't get the abortion pill without an ultrasound - a hurdle for rural doctorsRead the original story w/Photo

    Aug 11, 2017 | CBC News

    Although the abortion pill is now available for free in Ontario, doctors say that getting the ultrasound needed before prescribing the drug can be difficult in rural areas. Laura Fraser is an award-winning journalist who writes about justice, politics and the human experience.

    Comment?

  3. ACLU Sues D.C. Metro After It Rejects Ad With Text Of First AmendmentRead the original story w/Photo

    Aug 10, 2017 | New Hampshire Public Radio -

    The four plaintiffs in a lawsuit against the Washington Metropolitan Area Transit Authority are from across the political spectrum: the ACLU, a health care group called Carafem that provides abortions, People for the Ethical Treatment of Animals, and conservative provocateur Milo Yiannopoulos. What they have in common is that the transit agency known as WMATA has rejected their advertisements, saying the ads ran counter to its guidelines.

    Comment?

  4. Corcept Therapeutics Incorporated (CORT) Director David L. Mahoney Sells 23,006 SharesRead the original story

    Aug 8, 2017 | IntersportsWire

    Corcept Therapeutics Incorporated Director David L. Mahoney sold 23,006 shares of the stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $12.50, for a total value of $287,575.00.

    Comment?

  5. Fast-track vs. delayed insertion of the levonorgestrel-releasing...Read the original story

    Aug 7, 2017 | CiteULike

    To compare levonorgestrel 52-mg intrauterine system expulsion rates with fast track or delayed insertion following mifepristone and misoprostol medical abortion. In this pilot trial we randomized 108 womena< 63days gestation to fast-track or delayed insertion.

    Comment?

  6. LETTER: Abortion pill not necessaryRead the original story w/Photo

    Aug 4, 2017 | The Guardian

    I have to comment on the article that appeared in, The Guardian, August 2, 2017, entitled, "Fund abortion drug in P.E.I., say medical students." Why are medical students lobbying the P.E.I. government for the abortion drug? We already have medical abortion services in Summerside.

    Comment?

  7. David L. Mahoney Sells 6,510 Shares of Corcept Therapeutics Incorporated (CORT) StockRead the original story w/Photo

    Aug 3, 2017 | IntersportsWire

    Corcept Therapeutics Incorporated Director David L. Mahoney sold 6,510 shares of the stock in a transaction that occurred on Wednesday, July 12th. The shares were sold at an average price of $12.50, for a total value of $81,375.00.

    Comment?

  8. Ontario to cover cost of abortion pillRead the original story

    Aug 3, 2017 | The Toronto Star

    Indira Naidoo-Harris, Ontario's Minister of the Status of Women and Minister Responsible for Early Years and Child Care, announced Thusday that the province would cover the full cost of the abortion pill Mifegymiso starting Aug. 10. The abortion pill Mifegymiso will be dispensed for free to patients across the province starting Aug. 10, Ontario's Minister of the Status of Women said Thursday. Eliminating the fee for the drug is "about fairness, it's about safety, and it's the right thing to do," Indira Naidoo-Harris told a news conference at the Women's Health in Women's Hands Community Health Centre in Toronto.

    Comment?

  9. Medical students want P.E.I. to offer free access to abortion drugRead the original story w/Photo

    Aug 3, 2017 | CBC News

    The PEI Lobby Day team wants to meet with provincial decision-makers to ask that Mifegymiso be added to the provincial formulary so that it will be funded for women who would like to use it as a form of medical abortion. A group of medical students from Dalhousie University is lobbying the P.E.I. government to provide free access to Mifegymiso - an abortion drug.

    Comment?

  10. Medical treatment of second-trimester fetal miscarriage; A retrospective analysis.Read the original story

    Aug 2, 2017 | CiteULike

    Research on the treatment of second-trimester miscarriages is scarce. We studied the outcomes, and the factors associated with adverse events and need for hospital resources in the medical treatment of second-trimester miscarriage.

    Comment?

  11. Fund abortion drug in P.E.I.: medical studentsRead the original story w/Photo

    Aug 2, 2017 | Journal-Pioneer

    Medical students at Dalhousie University are planning a lobby day in Prince Edward Island in an effort to convince the P.E.I. government to cover the cost of the abortion drug Mifegymiso for Island women. A notice was sent to P.E.I. MLAs last month advising them that a group of Dalhousie medical students will be travelling to P.E.I. on Sept.

    Comment?

  12. Abortion drug now available in AlbertaRead the original story w/Photo

    Aug 1, 2017 | St. Albert Gazette

    Albertans now have free access to legal medical abortion drugs, the province announced. It joins New Brunswick and Ontario in offering universal coverage of RU-486 known by its trade name Mifegymiso to all people covered by provincial health care.

    Comment?

  13. Insider Selling: Corcept Therapeutics Incorporated (CORT) Director Sells 6,091 Shares of StockRead the original story w/Photo

    Jul 31, 2017 | IntersportsWire

    Corcept Therapeutics Incorporated Director David L. Mahoney sold 6,091 shares of Corcept Therapeutics stock in a transaction that occurred on Tuesday, July 18th. The shares were sold at an average price of $12.50, for a total value of $76,137.50.

    Comment?

  14. P.E.I. undecided on whether it will cover cost of abortion drugRead the original story w/Photo

    Jul 28, 2017 | CBC News

    Two years after the abortion drug Mifegymiso was approved for use by Health Canada, P.E.I. says it is still exploring the whether or not it will cover the cost for Islanders. New Brunswick recently announced it will offer Mifegymiso, also known as RU-486, free to women with a valid health card.

    Comment?

  15. Corcept Therapeutics Inc. To Announce Second Quarter Financial...Read the original story

    Jul 25, 2017 | BioSpace

    Corcept Therapeutics Incorporated today announced it will report its second quarter 2017 financial results and provide a corporate update on August 1, 2017. The Company will also host a conference call that day at 5:00 p.m. Eastern Time .

    Comment?

  16. N.B. Premier says funding abortion pills is the "right thing to do"Read the original story w/Photo

    Jul 18, 2017 | Yorkton This Week & Enterprise

    New Brunswick Premier Brian Gallant and Yukon Premier Sandy Silver walk together on the way to a group photo for the premiers during the Council of Federation meetings in Edmonton Alta, on Tuesday July 18, 2017. THE CANADIAN PRESS/Jason Franson New Brunswick Premier Brian Gallant and Yukon Premier Sandy Silver walk together on the way to a group photo for the premiers during the Council of Federation meetings in Edmonton Alta, on Tuesday July 18, 2017.

    Comment?

  17. Alberta latest province to cover the cost of abortion pill MifegymisoRead the original story w/Photo

    Jul 25, 2017 | The Chronicle-Journal

    She says it will help women who live in rural areas who have had to travel to urban centres for surgical abortions. Before taking the drug, women must undergo an ultrasound to rule out potential health risks and to determine the age of gestation.

    Comment?

  18. Abortion by pillsRead the original story w/Photo

    Jul 25, 2017 | NewsReview.com

    Bleeding, oozing, draining - spending four hours in the bathroom gives a woman plenty of time to think. There are abdominal cramps.

    Comment?

  19. David L. Mahoney Sells 6,510 Shares of Corcept Therapeutics Incorporated (CORT) StockRead the original story w/Photo

    Jul 24, 2017 | IntersportsWire

    Corcept Therapeutics Incorporated Director David L. Mahoney sold 6,510 shares of the company's stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $12.50, for a total transaction of $81,375.00.

    Comment?

  20. Corcept Therapeutics Incorporated (CORT) Receives Consensus Rating of ...Read the original story w/Photo

    Jul 21, 2017 | AmericanBankingNews.com

    Corcept Therapeutics Incorporated has earned a consensus recommendation of "Buy" from the seven brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company.

    Comment?